TGF-β-MTA1-SMAD7-SMAD3-SOX4-EZH2 Signaling Axis Promotes Viability, Migration, Invasion and EMT of Hepatocellular Carcinoma Cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TGF-β-MTA1-SMAD7-SMAD3-SOX4-EZH2 Signaling Axis Promotes Viability, Migration, Invasion and EMT of Hepatocellular Carcinoma Cells
Authors
Keywords
-
Journal
Cancer Management and Research
Volume Volume 13, Issue -, Pages 7087-7099
Publisher
Informa UK Limited
Online
2021-09-09
DOI
10.2147/cmar.s297765
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1
- (2020) Jie Su et al. NATURE
- EZH2: a novel target for cancer treatment
- (2020) Ran Duan et al. Journal of Hematology & Oncology
- DSTYK Promotes Metastasis and Chemoresistance via EMT in Colorectal Cancer
- (2020) Jinyu Zhang et al. Frontiers in Pharmacology
- Metastasis-Associated 1 (MTA1) Gene Expression Promotes Angiogenesis in Mouse Xenografts from Human Non-Small Cell Lung Cancer (NSCLC) Cells
- (2019) Tao Wang et al. MEDICAL SCIENCE MONITOR
- Epidemiological and etiological variations in hepatocellular carcinoma
- (2019) Evangelista Sagnelli et al. INFECTION
- Identification of a four‐gene metabolic signature predicting overall survival for hepatocellular carcinoma
- (2019) Gao‐Min Liu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- SOX4: Epigenetic regulation and role in tumorigenesis
- (2019) Hamza Hanieh et al. SEMINARS IN CANCER BIOLOGY
- Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma
- (2019) Peter R. Galle et al. LIVER INTERNATIONAL
- PRC2‐complex related dysfunction in overgrowth syndromes: A review of EZH2 , EED , and SUZ12 and their syndromic phenotypes
- (2019) Sharri Cyrus et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS
- EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications
- (2019) Boheng Li et al. Journal of Hematology & Oncology
- Differential alternative splicing regulation among hepatocellular carcinoma with different risk factors
- (2019) Young-Joo Jin et al. BMC Medical Genomics
- Discovery of a first-in-class EZH2 selective degrader
- (2019) Anqi Ma et al. Nature Chemical Biology
- Tumour evolution in hepatocellular carcinoma
- (2019) Amanda J. Craig et al. Nature Reviews Gastroenterology & Hepatology
- A TGF-β-MTA1-SOX4-EZH2 signaling axis drives epithelial–mesenchymal transition in tumor metastasis
- (2019) Lina Li et al. ONCOGENE
- Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients
- (2019) Diamantis I. Tsilimigras et al. SURGERY
- KIAA0247 inhibits growth, migration, invasion of non-small-cell lung cancer through regulating the Notch pathway
- (2018) Yitong Xu et al. CANCER SCIENCE
- EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis
- (2018) Shaofei Chen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Histone Methyltransferase EZH2: A Therapeutic Target for Ovarian Cancer
- (2018) Bayley A. Jones et al. MOLECULAR CANCER THERAPEUTICS
- HANR promotes hepatocellular carcinoma progression via miR-214/EZH2/TGF-β axis
- (2018) Yang Shi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer
- (2018) Krzysztof Marek Mrozik et al. BMC CANCER
- EZH2 is associated with poor prognosis in head-and-neck squamous cell carcinoma via regulating the epithelial-to-mesenchymal transition and chemosensitivity
- (2016) Jae Won Chang et al. ORAL ONCOLOGY
- Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer
- (2016) H. Zhang et al. Cancer Discovery
- A crucial epithelial to mesenchymal transition regulator, Sox4/Ezh2 axis is closely related to the clinical outcome in pancreatic cancer patients
- (2015) SHINICHIRO HASEGAWA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
- (2015) Mark A. Feitelson et al. SEMINARS IN CANCER BIOLOGY
- Role of MTA1 in cancer progression and metastasis
- (2014) Nirmalya Sen et al. CANCER AND METASTASIS REVIEWS
- E-Cadherin and Gastric Cancer: Cause, Consequence, and Applications
- (2014) Xin Liu et al. Biomed Research International
- World Medical Association Declaration of Helsinki
- (2013) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- MTA1-mediated transcriptional repression of SMAD7 in breast cancer cell lines
- (2012) Shimul Salot et al. EUROPEAN JOURNAL OF CANCER
- Smad7 suppresses renal fibrosis via altering expression of TGF-β/Smad3-regulated microRNAs
- (2012) Arthur C.K. Chung et al. MOLECULAR THERAPY
- The Polycomb complex PRC2 and its mark in life
- (2011) Raphaël Margueron et al. NATURE
- AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective
- (2010) J. E. Talmadge et al. CANCER RESEARCH
- Role of Smad2/3 and p38 MAP kinase in TGF-β1-induced epithelial-mesenchymal transition of pulmonary epithelial cells
- (2010) Irina Kolosova et al. JOURNAL OF CELLULAR PHYSIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now